Active invasion of bacteria into living fungal cells

  1. Nadine Moebius
  2. Zerrin Üzüm
  3. Jan Dijksterhuis
  4. Gerald Lackner
  5. Christian Hertweck  Is a corresponding author
  1. Leibniz Institute for Natural Product Research and Infection Biology, Germany
  2. Applied and Industrial Mycology, CBS, Netherlands

Abstract

The rice seedling blight fungus Rhizopus microsporus and its endosymbiont Burkholderia rhizoxinica form an unusual, highly specific alliance to produce the highly potent antimitotic phytotoxin rhizoxin. Yet, it has remained a riddle how bacteria invade into the fungal cells. Genome mining for potential symbiosis factors and functional analyses revealed that a type 2 secretion system (T2SS) of the bacterial endosymbiont is required for the formation of the endosymbiosis. Comparative proteome analyses show that the T2SS releases chitinolytic enzymes (chitinase, chitosanase) and chitin-binding proteins. The genes responsible for chitinolytic proteins and T2SS components are highly expressed during infection. Through targeted gene knock-outs, sporulation assays and microscopic investigations we found that chitinase is essential for bacteria to enter hyphae. Unprecedented snapshots of the traceless bacterial intrusion were obtained using cryo-electron microscopy. Beyond unveiling the pivotal role of chitinolytic enzymes in the active invasion of a fungus by bacteria, these findings grant unprecedented insight into the fungal cell wall penetration and symbiosis formation.

Article and author information

Author details

  1. Nadine Moebius

    Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Zerrin Üzüm

    Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Jan Dijksterhuis

    Applied and Industrial Mycology, CBS, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Gerald Lackner

    Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Christian Hertweck

    Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
    For correspondence
    christian.hertweck@hki-jena.de
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Thorsten Nürnberger, University of Tübingen, Germany

Version history

  1. Received: April 3, 2014
  2. Accepted: August 29, 2014
  3. Accepted Manuscript published: September 2, 2014 (version 1)
  4. Version of Record published: September 17, 2014 (version 2)

Copyright

© 2014, Moebius et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,055
    views
  • 834
    downloads
  • 102
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nadine Moebius
  2. Zerrin Üzüm
  3. Jan Dijksterhuis
  4. Gerald Lackner
  5. Christian Hertweck
(2014)
Active invasion of bacteria into living fungal cells
eLife 3:e03007.
https://doi.org/10.7554/eLife.03007

Share this article

https://doi.org/10.7554/eLife.03007

Further reading

  1. Bacteria and fungal cells join forces to cause rice seedling blight.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Natalia E Ketaren, Fred D Mast ... John D Aitchison
    Research Advance

    To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to previous variants poses a significant challenge. A compelling new therapeutic strategy against SARS-CoV-2 is that of single-domain antibodies, termed nanobodies, which address certain limitations of monoclonal antibodies. Here, we demonstrate that our high-affinity nanobody repertoire, generated against wild-type SARS-CoV-2 spike protein (Mast et al., 2021), remains effective against variants of concern, including omicron BA.4/BA.5; a subset is predicted to counter resistance in emerging XBB and BQ.1.1 sublineages. Furthermore, we reveal the synergistic potential of nanobody cocktails in neutralizing emerging variants. Our study highlights the power of nanobody technology as a versatile therapeutic and diagnostic tool to combat rapidly evolving infectious diseases such as SARS-CoV-2.